Biocon-Serum Combine Forces, mRNA Opportunities On Radar

Investments In Vaccine Supply Chain Likely

 
• By Anju Ghangurde and Vibha Ravi
KMS and Adar
Serum Institute, Biocon Biologics Form Powerful Alliance • Source: Company

More from COVID-19

More from Scrip